20.07.2022 • News

Azelis Buys Malaysia’s ChemSol

Azelis is acquiring Chemical Solutions (ChemSol), a distributor of raw materials for the personal care, cosmetics and household market segments in Malaysia.

The proposed deal will strengthen Azelis’ presence in the Malaysian market and in the Asia-Pacific personal care sector through the addition of ChemSol’s “extensive and well-known” product portfolio, specifically in actives and functional ingredients.

“ChemSol’s strong market presence, comprehensive portfolio and innovation capabilities will greatly enhance Azelis’ footprint in Malaysia, along with the addition of their experienced and technically competent team. Our complementary business models also allow us to better support our customers and principals, as they will benefit from our combined technical expertise and compelling expanded product offerings,” said Laurent Nataf, CEO and president of Azelis Asia-Pacific.

ChemSol is headquartered in Shah Alam, Selangor, and has a dedicated personal care application laboratory. All of ChemSol’s employees will become part of  the Azelis team when the transaction closes, expected before the end of the ongoing third quarter.

There has been no letup in Azelis’ buying spree this year, with ChemSol the ninth deal agreed so far. Acquisitions have been made in the Middle East, Turkey, India, Colombia, Thailand and the UK, boosting the distributor’s presence around the world.

Author: Elaine Burridge, Freelance Journalist

© Toto Jang/ Shutterstock
© Toto Jang/ Shutterstock

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.